
The logic of selling cheaper 'generics' for drug companies such as Mylan
Sep 03, 2016 11:05 am UTC| Insights & Views Business
Mylan is the latest pharmaceutical company to face controversy over its drug pricing. It has come under scrutiny and strong criticism from the public and government officials for raising the price of its EpiPen allergy...
Sep 03, 2016 02:50 am UTC| Business
SALT LAKE CITY, Sept. 02, 2016 -- Park City Group, Inc. (NASDAQ:PCYG), a cloud-based software company that uses big data management to help retailers and their suppliers ‘Sell more, Stock less and See everything’, today...
Sep 03, 2016 02:07 am UTC| Business
NEW ORLEANS, Sept. 02, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 19, 2016 to file lead...
Sep 03, 2016 00:30 am UTC| Business
NEW YORK, Sept. 02, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Juno Therapeutics, Inc. (“Juno” or the “Company”) (NASDAQ:JUNO) and certain of its officers. The class action, filed...
Sep 03, 2016 00:30 am UTC| Business
NEW YORK, Sept. 02, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Flowers Foods, Inc. (“Flowers Foods” or the “Company”) (NYSE:FLO) and certain of its officers. The class action,...
Sep 03, 2016 00:30 am UTC| Business
NEW YORK, Sept. 02, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against The Hain Celestial Group, Inc. (“Hain” or the “Company”) (NASDAQ:HAIN) and certain of its officers. The class...
Communications Sales & Leasing Announces $250 Million ATM Equity Offering Program
Sep 02, 2016 21:05 pm UTC| Business
LITTLE ROCK, Ark., Sept. 02, 2016 -- Communications Sales Leasing, Inc. (“CSL” or the “Company”) (Nasdaq:CSAL) today announced the establishment of an “at the market” equity offering program, pursuant to which the...